Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children

被引:45
|
作者
Catt, Caroline J. [1 ,3 ,4 ,5 ]
Hamilton, Gavin M. [3 ]
Fish, Joel [2 ,3 ]
Mireskandari, Kamiar [1 ,3 ]
Ali, Asim [1 ,3 ]
机构
[1] Hosp Sick Children, Dept Ophthalmol & Vis Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Div Plast Surg, Burn Unit, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Childrens Hosp Westmead, Sydney, NSW, Australia
[5] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia
关键词
ERYTHEMA MULTIFORME; COMPLICATIONS; MANAGEMENT;
D O I
10.1016/j.ajo.2016.03.020
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To describe the acute and chronic ocular manifestations of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN Overlap syndrome (Overlap syndrome) in children. DESIGN: Retrospective case series. METHODS: Medical records of children admitted to the Hospital for Sick Children between 2001 and 2011 with SJS, TEN, and Overlap syndrome were reviewed. Demographic information, all abnormal ophthalmic findings (and median time to first diagnosis), visual acuities, and ophthalmic treatments prescribed were collected for each eye for every patient. RESULTS: Thirty-six children were identified for inclusion in the study. Twenty-nine (81%) had acute ocular involvement, including all patients with TEN (n = 7). Conjunctivitis was the most common (78%) clinical sign. This, together with conjunctival membranes and subconjunctival hemorrhage, were the earliest signs, presenting by a median of 1 day. The percentage of patients and median time to occurrence of complications were as follows: for lid margin ulceration and corneal epithelial defects, 25%, 3 days; conjunctival ulceration, 39%, 3.5 days; symblepharon, 28%, 4 weeks; corneal opacification, 11%, 4 months; limbal stem cell failure, 8%, 7 months; and corneal vascularisation, 8%, 10 months after admission. Over 90% of children maintain a visual acuity of 20/40 or better in each eye at a mean follow-up of 1.4 years. CONCLUSIONS: Ocular involvement in SJS, TEN, and Overlap syndrome is common and the ocular manifestations may develop many months after the initial presentation, mandating the need for long-term follow-up of these children. Despite the high frequency of sight-threatening disease, most children maintain good vision in the long term. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:68 / 75
页数:8
相关论文
共 50 条
  • [41] Ocular manifestations in acute stage Stevens-Johnson syndrome/toxic epidermal necrolysis-A retrospective study in a tertiary hospital in south India
    Pradeep, Thanuja Gopal
    Shetti, Samyakta
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2022, 12 (02) : 184 - 190
  • [42] Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study
    Chow, Loraine L. W.
    Shih, Kendrick C.
    Chan, Johnny C. Y.
    Lai, Jimmy S. M.
    Ng, Alex L. K.
    BMC OPHTHALMOLOGY, 2017, 17
  • [43] Clinical Outcome of Amniotic Membrane Transplant in Ocular Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis at a Major Burn Unit
    Mortensen, Xavier M.
    Shenkute, Nathan T.
    Zhang, Alice Yang
    Banna, Hussam
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 256 : 80 - 89
  • [44] Ocular and Mucocutaneous Sequelae among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo
    Saka, Bayaki
    Akakpo, Abla Sefako
    Teclessou, Julienne Noude
    Mahamadou, Garba
    Mouhari-Toure, Abas
    Dzidzinyo, Kossi
    Diori, Adam Nouhou
    Maneh, Nidain
    Prince-Agbodjan, Sabin
    Kombate, Koussake
    Balo, Komi
    Tchangai-Walla, Kissem
    Pitche, Palokinam
    DERMATOLOGY RESEARCH AND PRACTICE, 2019, 2019
  • [45] Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis
    Antoon, James W.
    Goldman, Jennifer L.
    Lee, Brian
    Schwartz, Alan
    PEDIATRIC DERMATOLOGY, 2018, 35 (02) : 182 - 187
  • [46] Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Cartotto, Robert
    CLINICS IN PLASTIC SURGERY, 2017, 44 (03) : 583 - +
  • [47] Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan
    Ma, David Hui-Kang
    Tsai, Tsung-Ying
    Pan, Li-Yen
    Chen, Shin-Yi
    Hsiao, Ching-Hsi
    Yeh, Lung-Kun
    Tan, Hsin-Yuan
    Lu, Chun-Wei
    Chen, Chun-Bing
    Chung, Wen-Hung
    FRONTIERS IN MEDICINE, 2021, 8
  • [48] Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel
    Maggio, Nicola
    Firer, Maria
    Zaid, Huda
    Bederovsky, Yana
    Aboukaoud, Mohammed
    Gandelman-Marton, Revital
    Noyman, Iris
    Ekstein, Dana
    Blatt, Ilan
    Marom, Eli
    Schwartzberg, Eyal
    Israel, Shoshana
    Ingber, Arieh
    Brautbar, Chaim
    Eyal, Sara
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (07) : 823 - 829
  • [49] Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis
    Fritsch P.O.
    Sidoroff A.
    American Journal of Clinical Dermatology, 2000, 1 (6) : 349 - 360
  • [50] Managing respiratory complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Lee, Ken Cheah Hooi
    Ko, Joanna Phone
    Oh, Choon Chiat
    Sewa, Duu Wen
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : 660 - 666